Sabra Health Care REIT Inc.
SBRAFinancial Snapshot
ticker: SBRA step: 04 generated: 2026-05-13 source: quick-research
Sabra Health Care REIT Inc. (SBRA) — Financial Snapshot
Income Statement Summary
| Metric | FY2022 | FY2023 | FY2024 | YoY |
|---|---|---|---|---|
| Revenue | $647M | $703M | $733M | +4.2% |
| Gross Margin | ~65% | ~67% | ~68% | |
| Operating Margin | ~30% | ~32% | ~35% | |
| Net Income | ~$50M | ~$80M | ~$100M | |
| Normalized AFFO/Share | ~$1.25 | ~$1.35 | $1.44 | +7.0% |
GAAP net income is depressed by depreciation. Normalized AFFO is the primary metric — growing 7% in FY2024. Normalized FFO/share grew 7% to $1.39 in FY2024. Last-12-month FFO (as of early 2026): $370.7M, up from $321.6M a year earlier (+15.3%).
Cash Flow & Balance Sheet (FY2024)
| Metric | Value |
|---|---|
| Operating Cash Flow | ~$350M |
| Normalized AFFO | ~$370M |
| Cash & Equivalents | ~$50M |
| Total Debt | ~$3.0B |
| Net Debt / EBITDA | ~6.5x |
Key Ratios (approximate)
- P/Normalized AFFO: ~12x | EV/EBITDA: ~16x | Dividend Yield: ~6.4%
- Revenue Growth (FY2024): +4.2% | Normalized AFFO/Share Growth: +7.0%
- SHOP Sequential Revenue Growth (Q4 2024): +15.8%; Cash NOI Growth: +18.4%
- Payout Ratio: ~80% (80% payout on $1.495 FY2025 AFFO guidance)
Growth Profile
Sabra has delivered consistent 4–8% revenue growth since 2022, driven by improving SNF occupancy post-COVID, senior housing rent escalations, and acquisitions. The SHOP segment is the primary growth accelerator: managed senior housing NOI grew 18.4% sequentially in Q4 2024 as occupancy approached 88% (target: low-90s). The strategic shift toward 30% SHOP exposure by end-2026 is designed to capture the senior housing occupancy recovery cycle — Sabra's earnings growth should accelerate as SHOP occupancy improves and the portfolio mix shifts toward higher-margin managed assets.
Forward Estimates
- FY2025 Normalized AFFO/share guidance: $1.495
- FY2026 Normalized FFO/AFFO guidance growth: +4.9–5.4% at midpoint
- SHOP occupancy target: low-90% range (from ~88%)
- Investment target: >$500M in acquisitions (exceeding initial $500M guidance in 2025)
- Analysts: Bullish consensus; 12.7x 2026 FAD (vs. peer average ~20.6x — significant discount)
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $SBRA.